Office 100 mg/100 mg Tablet is a combination antibiotic formulation containing Cefixime 100 mg and Ofloxacin 100 mg, designed for the treatment of a wide range of bacterial infections. Cefixime, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Ofloxacin, a fluoroquinolone, interferes with bacterial DNA gyrase and topoisomerase IV, thereby inhibiting DNA replication and transcription. This synergistic action enhances the antibacterial spectrum, making Office effective against both Gram-positive and Gram-negative pathogens. It is commonly prescribed for urinary tract infections, respiratory tract infections, gastrointestinal infections, and sexually transmitted infections caused by susceptible organisms. The combination therapy helps reduce the risk of resistance development and improves clinical outcomes. Office 100 mg/100 mg Tablet should be used under medical supervision, with dosage and duration tailored according to the severity and type of infection. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and it is contraindicated in individuals with known tendon disorders related to fluoroquinolone use. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and hypersensitivity reactions. Complete the full prescribed course to prevent recurrence and resistance.